"Gilead quickly asks FDA for blockbuster hep C approval"
"Gilead has taken an application to the FDA for approval of its hep C pill sofosbuvir (GS-7977), positioning itself to become the first pharma group with a completely oral regimen on the U.S. market."
http://www.fiercebiotech.com/story/gilead-quickly-asks-fda-blockbuster-hep-c-approval/2013-04-08
I wonder how long it will take. My trial team said it would be on the market in 2014, can it happen that fast?